Whitehawk Therapeutics (WHWK)

• Market cap: $153M
• 1 day: -1.52%
• 5 days: 6.91%
• 1 month: 21.27%
• 3 months: 41.3%
• 6 months: 79.56%
• Year to date: 33.2%
• 1 year: 23.11%
• 5 years: -87.83%
• 10 years: -94.44%
• Sector: Healthcare
• Industry: Biotechnology

About: Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.

Employees: 22